Literature DB >> 8037515

Interobserver variability and accuracy of computed tomographic assessment of nodal status in lung cancer.

E C Bollen1, R Goei, B E van 't Hof-Grootenboer, C W Versteege, H A Engelshove, R J Lamers.   

Abstract

To assess the interobserver variability of computed tomography in determining nodal status in non-small cell lung carcinoma, four experienced radiologists reviewed the computed tomographic scans of 147 patients. Interobserver variability was calculated using the kappa statistic. In addition, the accuracy of CT assessment of the nodal status by the four observers was measured by comparing their findings with thorough mediastinal exploration at both mediastinoscopy (n = 35) and thoracotomy (n = 112). Interobserver variability was large between the four radiologists regarding nodal status on a per-patient basis (kappa = 0.38). Sensitivity of computed tomography for the observers on a per-patient basis ranged from 40% to 69% with a 1.0-cm criterion and from 28% to 56% with a 1.5-cm criterion. From the large interobserver variability and the low sensitivities in this study it can be concluded that a negative result of computed tomography regarding mediastinal lymph nodes does not eliminate the need for mediastinoscopy or exploration of the mediastinum at the time of operation in patients with non-small cell lung cancer.

Entities:  

Mesh:

Year:  1994        PMID: 8037515     DOI: 10.1016/0003-4975(94)91091-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Interobserver variability in the detection of mediastinal and hilar lymph nodes on CT in children with suspected pulmonary tuberculosis.

Authors:  Savvas Andronikou; Barbara Brauer; Jackie Galpin; Steven Brachmeyer; Susan Lucas; Elaine Joseph; George Dutoit; George Swingler
Journal:  Pediatr Radiol       Date:  2005-01-05

2.  Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience.

Authors:  Domenico Genovesi; Giampiero Ausili Cèfaro; Annamaria Vinciguerra; Antonietta Augurio; Monica Di Tommaso; Rita Marchese; Umberto Ricardi; Andrea Riccardo Filippi; Theodore Girinsky; Katiuscia Di Biagio; Maurizio Belfiglio; Enza Barbieri; Vincenzo Valentini
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

3.  Reinterpretation of cross-sectional images in patients with head and neck cancer in the setting of a multidisciplinary cancer center.

Authors:  Laurie A Loevner; Adina I Sonners; Brian J Schulman; Kerstin Slawek; Randal S Weber; David I Rosenthal; Gul Moonis; Ara A Chalian
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

4.  Virtual positron emission tomography/computed tomography-bronchoscopy: possibilities, advantages and limitations of clinical application.

Authors:  Marcus D Seemann; Juergen F Schaefer; Karl-Hans Englmeier
Journal:  Eur Radiol       Date:  2006-08-15       Impact factor: 5.315

5.  Sarcoidosis: assessment of disease severity using HRCT.

Authors:  Marjolein Drent; Jolanda De Vries; Merinke Lenters; Rob J S Lamers; Snjezana Rothkranz-Kos; Emiel F M Wouters; Marja P van Dieijen-Visser; Johny A Verschakelen
Journal:  Eur Radiol       Date:  2003-06-17       Impact factor: 5.315

6.  The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.

Authors:  Mohsen Beheshti; Sigrid Pöcher; Reza Vali; Peter Waldenberger; Gabriele Broinger; Michael Nader; Susanne Kohlfürst; Christian Pirich; Henning Dralle; Werner Langsteger
Journal:  Eur Radiol       Date:  2009-01-21       Impact factor: 5.315

7.  Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?

Authors:  Lindsay Brammen; Martin B Niederle; Philipp Riss; Christian Scheuba; Andreas Selberherr; Georgios Karanikas; Gerd Bodner; Oskar Koperek; Bruno Niederle
Journal:  Ann Surg Oncol       Date:  2018-10-10       Impact factor: 5.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.